Does remote ischaemic preconditioning reduce heart and cerebral damage following carotid endarterectomy? A randomised controlled trial

ISRCTN ISRCTN98544942
DOI https://doi.org/10.1186/ISRCTN98544942
Protocol serial number N/A
Sponsor Cambridge University Hospitals NHS Foundation Trust (UK)
Funder Cambridge Vascular Research Fund (UK)
Submission date
15/12/2005
Registration date
13/01/2006
Last edited
17/08/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr Michael Gaunt
Scientific

Consultant Vascular Surgeon
Level 7
Box 201
Addenbrooke's Hospital
Hills Road
Cambridge
CB2 2QQ
United Kingdom

Phone +44 (0)123 212246
Email michael.gaunt@addenbrookes.nhs.uk

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study objectivesCarotid endarterectomy is associated with a significant risk of stroke or myocardial infarction. This trial aims to determine whether remote ischaemic preconditioning reduces subclinical cerebral and myocardial damage among patients undergoing carotid endarterectomy.
Ethics approval(s)Reviewed and approved by an NHS Research Ethics Committee November 2005. The committee will review the results of the first 12 block randomised patients to determine if the trial should proceed any further.
Health condition(s) or problem(s) studiedCarotid stenosis
InterventionPatients randomised to undergo ischaemic preconditioning will have a thigh cuff inflated on one leg until flow in the pedal arteries disappears. After five minutes have elapsed, the cuff will be moved to the opposite thigh. The cycle will be repeated so that each leg has two five minute periods of ischaemia followed by five minutes of reperfusion.
Control: no ischaemic preconditioning.
Intervention typeOther
Primary outcome measure(s)

Primary neurological outcome: proportion of patients developing a significant change in saccadic latency as determined by quantitative oculometry.
Cardiac outcome: serial troponin I levels post-operatively.

Key secondary outcome measure(s)

Not provided at time of registration

Completion date01/01/2007

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration70
Key inclusion criteriaPatients undergoing elective carotid endarterectomy.
Key exclusion criteria1. Patients with an ankle-brachial pressure index less than 0.7
2. Patients who have undergone previous lower limb amputation
3. Blind patients
Date of first enrolment01/01/2006
Date of final enrolment01/01/2007

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Consultant Vascular Surgeon
Cambridge
CB2 2QQ
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/08/2010 Yes No